Zobrazeno 1 - 7
of 7
pro vyhledávání: '"LG Gorenkova"'
Autor:
Ya.K. Mangasarova, F.E. Babaeva, S K Kravchenko, R G Shmakov, Aminat U. Magomedova, E S Nesterova, LG Gorenkova
Publikováno v:
Clinical oncohematology. 13:316-321
Background. The management of aggressive lymphomas in pregnancy depends on the time of diagnosis and immu-nomorphological variant of tumor. The rarity of aggressive lymphomas in pregnant women, the absence of consistent approaches to the treatment of
Autor:
DS Badmadzhapova, Alla M. Kovrigina, E E Zvonkov, AK Smol’yaninova, Mamonov Ve, EG Gemdzhian, SA Tatarnikova, N G Gabeeva, LG Gorenkova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 3, Pp 247-262 (2019)
Background. Primary bone lymphomas (PBL) are rare extranodal lymphomas. In more than 90 % of cases they are reported as diffuse large B-cell lymphomas (DLBCL). At local (IE) stage of PBL the standard R-CHOP immunotherapy demonstrates efficacy over 90
Autor:
EA Penskaya, A E Misyurina, V. V. Tikhonova, LG Gorenkova, NN Kasatkina, L. A. Kesaeva, V. A. Misyurin, N. A. Lyzhko, YuP Finashutina, A. V. Misyurin, L V Plastinina, O. N. Solopova, S K Kravchenko
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 1, Pp 73-78 (2018)
Background. T-cell lymphomas (T-CL) represent a heterogeneous group of malignant lymphoproliferative disorders characterized by unfavorable prognosis. The cancer-testis PRAME gene is notable for its spontaneous expression in transformed cells as obse
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 3, Pp 366-371 (2017)
Background. The most common diseases among cutaneous T-cell lymphomas are mycosis fungoides (MF) and its leukemic variant Sezary Syndrome (SS). These malignant tumors have a progressive character course. To date, no therapy for these diseases has pro
Autor:
Magomedova AU; National Research Center for Hematology, Department of Intensive High-Dose Chemotherapy with Round-the-Clock and Day Hospital (IVHT with CS and DS)., Misyurina AE; National Research Center for Hematology, Department of Intensive High-Dose Chemotherapy with Round-the-Clock and Day Hospital (IVHT with CS and DS)., Mangasarova JK; National Research Center for Hematology, Department of Intensive High-Dose Chemotherapy with Round-the-Clock and Day Hospital (IVHT with CS and DS)., Gorenkova LG; National Research Center for Hematology, Department of Intensive High-Dose Chemotherapy with Round-the-Clock and Day Hospital (IVHT with CS and DS)., Margolin OV; National Research Center for Hematology, Department of Intensive High-Dose Chemotherapy with Round-the-Clock and Day Hospital (IVHT with CS and DS)., Fastova EA; National Research Center for Hematology, Department of Intensive High-Dose Chemotherapy with Round-the-Clock and Day Hospital (IVHT with CS and DS)., Kravchenko SK; National Research Center for Hematology, Department of Intensive High-Dose Chemotherapy with Round-the-Clock and Day Hospital (IVHT with CS and DS).
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2019 Jul 15; Vol. 91 (7), pp. 35-40. Date of Electronic Publication: 2019 Jul 15.
Autor:
Olisova OY; Department of Skin and Sexually Transmitted Diseases, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Megna M; Section of Dermatology, Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Saint Petersburg, Russia., Grekova EV; Department of Skin and Sexually Transmitted Diseases, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Zaslavsky DV; Department of Dermatovenereology, Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russia., Gorenkova LG; National Medical Hematology Research Center, Moscow, Russia., Sidikov AA; Department of Dermatovenereology, Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russia., Timoshchuk EA; Department of Dermatovenereology, Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russia.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2019 Feb; Vol. 33 (2), pp. e72-e74. Date of Electronic Publication: 2018 Sep 05.
Autor:
Olisova OY; V.A. Rakhmanov Department of Skin and Venereal Diseases, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia., Grekova EV; V.A. Rakhmanov Department of Skin and Venereal Diseases, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia., Varshavsky VA; Acad. A.I. Strukov Department of Pathological Anatomy, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia., Gorenkova LG; National Medical Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia., Alekseeva EA; Laboratory of Medical Genetics, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia; Laboratory of Epigenetics, Research Center for Medical Genetics, Moscow, Russia., Zaletaev DV; Laboratory of Medical Genetics, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia; Laboratory of Epigenetics, Research Center for Medical Genetics, Moscow, Russia., Sydikov AA; Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia, Saint Petersburg, Russia.
Publikováno v:
Arkhiv patologii [Arkh Patol] 2019; Vol. 81 (1), pp. 9-17.